Mann Eye Institute
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Mann Eye Institute sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
Mann Eye Institute: 6 sponsored US clinical trials, 2 recruiting.
Mann Eye Institute sponsors 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 4 completed. The most-studied condition in this pipeline is Myopia, with 2 trials.
Upper-quartile sponsor footprint
Mann Eye Institute sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
6 total, page 1 of 1
IOP Reduction in Pigmentary Glaucoma Using DSLT
NCT07281391
Patient Reported Outcomes With WaveLight Plus LASIK
NCT07084844
RLE Outcomes With Bilateral Implantation of Odyssey IOLs
NCT06979557
Clinical Outcomes With Bilateral Implantation of Odyssey IOLs
NCT06550375
Success of Dailies Total1 for Astigmatism Contact Lenses in Patients That Have Previously Failed With Toric Contact Lenses
NCT05886452
Patient Reported Satisfaction With Contoura LASIK Utilizing the Phorcides Analytic Software
NCT05848817
Therapeutic Areas
What is open in the Mann Eye Institute pipeline
2 recruiting of 6 indexed (33% open); 4 completed (67%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Myopia (2 trials), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Mann Eye Institute: open-pipeline peers nationwide
Peers matched on 6 registered trials and 33% open enrollment, not the therapeutic-area sidebar.
Mann Eye Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 trials (± recruiting share)
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors near 33% open enrollment (± trial volume)
- Aadi Bioscience · 33% recruiting · 9 trials
- Aaron Cook · 33% recruiting · 3 trials
- Abivax S.A. · 33% recruiting · 6 trials
- Actuated Medical · 33% recruiting · 3 trials
Related
What to do with this Mann Eye Institute page
6 registered trials is a research-attention snapshot, not an endorsement of Mann Eye Institute or any single study.
- 2 of Mann Eye Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Myopia is the condition Mann Eye Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Myopia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Mann Eye Institute pipeline card: 6 registered trials from official public datasets.Report a data error.